
    
      This is a Phase I study to investigate the safety and tolerability of AZD4831 in healthy male
      participants, conducted at a single center.The results from this study will form the basis
      for decisions on future studies. Another purpose of this dose escalation study is to find out
      the right dose of the experimental drug to be given to study participants in future studies.
      The study will be conducted in healthy participants to avoid interference from disease
      processes or other drugs. The participants will stay at the study center during the whole
      dosing period and until 48 hours post final dose.
    
  